The European School of Multimodality Imaging & Therapy (ESMIT) https://validator.w3.org/feed/docs/rss2.html Focus on FDG PET/CT in Inflammatory and Infectious Diseases Incidental Findings and Limitations of Bone Scan Radioguided Surgery (in Valencia, Spain) Hybrid SPECT and PET in Nuclear Cardiology: Together Better Than Alone Tau-PONG: Practically Oriented and Advanced Tau-PET Assessment in Neurodegenerative Diseases What’s New in Radiopharmaceutical Regulations Which Dosimetry for Which Treatment? Nuclear Medicine in Breast Cancer Update in PET Imaging of Large Vessel Vasculitis Beyond the Patient: Radiation Protection Management for Healthcare Workers and the Public in a Theranostic Centre Guidelines Meet Reality in Nuclear Cardiology Perfusion Imaging Updates on FAPI Pretargeted Radioligand Therapy with Alpha Emitters: A New Route to High Tumour Dose with Less Toxicity? How can you Monitor the Immune System Activity in Patients? Developments of Dosimetry in Combined MRT and EBRT Non-oncological PET Applications Networks in Nuclear Medicine: What, Why, How? Lutetium-177 PSMA Therapy & Diagnostic Imaging: The Technologist’s Role in Theranostic Workflows Best Practices and Pitfalls of Using LLMs in Nuclear Medicine Programme 2027 Neuroimaging in the Diagnosis of Movement Disorders NucMed Essentials Impressions Live Webinars Nuclear Cardiology Certification Home eLearning AD-LEARN Data Privacy EURO-LEARN About General Information Courses eLearning Platform External Links ESMIT QuizUp App Collaborations with Other Societies Biomarker Assessment for an Early Biological Diagnosis of Alzheimer’s Disease Empathetic Communication Professional Development Your Voice Matters: EANM/ESMIT Education Survey Prostate Cancer Theranostics NucMed Essentials – Artifical Intelligence Basics Difficult Conversations in the Workplace – Professional Development Track Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease Trustworthy AI and Human Oversight RLT Academy Programme 2026 JSNM/ESMIT – SPECT and PET in the Contemporary Assessment of Cardiac Amyloidosis Organs